← back to search

Kun Song

Qilu Hospital of Shandong University · CN
Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Nanoplatforms for cancer theranostics, and PARP inhibition in cancer therapy.
h-index
35
citations
4,176
works
299
NIH funding
primary concept
Medicine
email

Recent publications

Correction: The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
2026cited by 0position: contributordoi
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.
2026cited by 0position: contributordoi
Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer.
2025cited by 37position: contributordoi
Enhancing the antitumor effect of MUC16 CART cells in ovarian cancer: The potential of oncolytic adenovirus
Cancer Letters 2025cited by 3position: middledoi
Therapeutic application of MUC16-BiTE oncolytic adenovirus combined with MUC16-targeted CAR T cells in ovarian cancer
European Journal of Obstetrics & Gynecology and Reproductive Biology 2025cited by 0position: middledoi
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.
2025cited by 0position: contributordoi
Spliceosomal GTPase EFTUD2 mediates DDX41 intron retention to promote the malignant progression of ovarian cancer.
2025cited by 0position: contributordoi
Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation
Nature Communications 2024cited by 16position: middledoi
The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
2024cited by 15position: contributordoi
Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation.
2024cited by 13position: contributordoi
Temperature‐sensitive hydrogel releasing pectolinarin facilitate scarless wound healing
Journal of Cellular and Molecular Medicine 2024cited by 10position: middledoi
Radical partial vulvectomy combined with through vulva incision laparoendoscopic single-site inguinal lymphadenectomy for vulva cancer.
2024cited by 0position: contributordoi
Medical Education Systems in China: Development, Status, and Evaluation.
2023cited by 43position: contributordoi
Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer.
2023cited by 26position: contributordoi
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors.
2023cited by 10position: contributordoi
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
2023cited by 6position: contributordoi
Radiomics-based fertility-sparing treatment in endometrial carcinoma: a review.
2023cited by 4position: contributordoi
Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse
Journal of Ovarian Research 2023cited by 0position: lastdoi
Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study
The Lancet Digital Health 2022cited by 176position: middledoi
Medical Education Systems in China: Development, Status, and Evaluation
Academic Medicine 2022cited by 76position: lastdoi
Risk Factors and Prognosis of Early Recurrence in Stage I–II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study
Frontiers in Medicine 2022cited by 15position: middledoi
Comprehensive Analysis of NAC Genes Reveals Differential Expression Patterns in Response to Pst DC3000 and Their Overlapping Expression Pattern during PTI and ETI in Tomato
Genes 2022cited by 14position: middledoi
Prognostic-Related Metabolic Score for Survival Prediction in Early-Stage Endometrioid Endometrial Cancer: A Multi-Center and Retrospective Study
Frontiers in Medicine 2022cited by 2position: middledoi
Efficacy of PARPi monotherapy and the impact to subsequent platinum-based chemotherapy in BRCA1/2 mutant ovarian cancer patients with secondary platinum-sensitive relapse
2022cited by 0position: firstdoi
X-ray triggered pea-shaped LuAG:Mn/Ca nano-scintillators and their applications for photodynamic therapy.
2022cited by 0position: contributordoi
Progress in the management of ovarian granulosa cell tumor: A review.
2021cited by 28position: contributordoi
Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm.
2021cited by 16position: contributordoi
Hyperemesis gravidarum induced refeeding syndrome causes blood cell destruction: a case report and literature review.
2021cited by 2position: contributordoi
A bio-based benzoxazine surfactant from amino acids
Green Chemistry 2020cited by 38position: middledoi
Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro
Scientific Reports 2017cited by 170position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2023–2026)Xiaohua Wu · Shanghai Medical College of Fudan University2 papers (2025–2026)Yongwen Huang · Sun Yat-sen University2 papers (2022–2023)Hualei Bu · Shandong University2 papers (2022–2023)Shuai Feng · Kunming University of Science and Technology2 papers (2022–2023) · 2 papers (2022–2025)Shu Yao · Shandong University2 papers (2017–2020) · 2 papers (2022–2023) · 2 papers (2022–2023)Beihua Kong · Chinese Center For Disease Control and Prevention2 papers (2017–2023)Qiuman Wang · Hebei Medical University2 papers (2025–2025)Lingying Wu · State Key Laboratory of Electronic Thin Films and Integrated Devices2 papers (2022–2023)Cunzhong Yuan · Shandong University2 papers (2025–2025)Hui Zhang · Shihezi University2 papers (2022–2023)Li Li · Shandong University2 papers (2017–2022)Ning Li · Shenyang Pharmaceutical University2 papers (2022–2023)Li‐Ping Sun · KU Leuven1 papers (2017–2017)Jiale Liu · Soochow University1 papers (2023–2023)Yuan Zhang · Shandong University1 papers (2024–2024)Yan Shi · Fudan University1 papers (2025–2025)